AU2003257591A1 - Preventive and/or therapeutic agent for heart failure - Google Patents

Preventive and/or therapeutic agent for heart failure

Info

Publication number
AU2003257591A1
AU2003257591A1 AU2003257591A AU2003257591A AU2003257591A1 AU 2003257591 A1 AU2003257591 A1 AU 2003257591A1 AU 2003257591 A AU2003257591 A AU 2003257591A AU 2003257591 A AU2003257591 A AU 2003257591A AU 2003257591 A1 AU2003257591 A1 AU 2003257591A1
Authority
AU
Australia
Prior art keywords
preventive
therapeutic agent
heart failure
heart
failure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003257591A
Inventor
Nobuakira Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of AU2003257591A1 publication Critical patent/AU2003257591A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003257591A 2002-08-30 2003-08-29 Preventive and/or therapeutic agent for heart failure Abandoned AU2003257591A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-254654 2002-08-30
JP2002254654 2002-08-30
PCT/JP2003/011011 WO2004019926A1 (en) 2002-08-30 2003-08-29 Preventive and/or therapeutic agent for heart failure

Publications (1)

Publication Number Publication Date
AU2003257591A1 true AU2003257591A1 (en) 2004-03-19

Family

ID=31972848

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003257591A Abandoned AU2003257591A1 (en) 2002-08-30 2003-08-29 Preventive and/or therapeutic agent for heart failure

Country Status (4)

Country Link
JP (1) JPWO2004019926A1 (en)
AU (1) AU2003257591A1 (en)
TW (1) TW200406199A (en)
WO (1) WO2004019926A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
JPH02304022A (en) * 1989-05-18 1990-12-17 Mitsubishi Kasei Corp Serotonin antagonistic agent
JP2544239B2 (en) * 1989-08-31 1996-10-16 花王株式会社 Vasodilator
US5585361A (en) * 1994-06-07 1996-12-17 Genzyme Corporation Methods for the inhibition of platelet adherence and aggregation
CN1299690C (en) * 2000-07-28 2007-02-14 生物能量公司 Compositions and methods for improving cardiovascular function
PL209375B1 (en) * 2000-12-28 2011-08-31 Kissei Pharmaceutical Glucopyranosyloxypyrazole derivatives and use thereof in medicines

Also Published As

Publication number Publication date
JPWO2004019926A1 (en) 2005-12-15
WO2004019926A1 (en) 2004-03-11
TW200406199A (en) 2004-05-01

Similar Documents

Publication Publication Date Title
AU2003256253A1 (en) Aerosol for medical treatment and methods
AU2003296379A1 (en) Methods and devices for cardiac surgery
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU2003229923A1 (en) Curcumin for the prevention and/or treatment of tissue damage
EP1476471A4 (en) Nutraceuticals for the treatment, protection and restoration of connective tissues
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU2003214725A1 (en) Preventing and/or treating cardiovascular disease and/or associated heart failure
AU2003294318A1 (en) Therapeutic bioconjugates
PL373432A1 (en) Method for treating severe heart failure and medicament therefor
AU2002367023A1 (en) Compositions and methods for treating heart failure
AU2003221042A1 (en) Preventive or therapeutic agent for kidney disease
AU2003236290A1 (en) Severe sepsis preventive therapeutic agent
AU2002365057A1 (en) Compositions and methods for treating heart failure
AU2003232115A1 (en) Methods and compositions for the treatment of graft failure
EP1406648A4 (en) The use of angiotensin i derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders
AU2003262230A1 (en) Preventive and/or therapeutic drugs for itch
AU2003262229A1 (en) Preventive and/or therapeutic drugs for asthma
AU2002249947A1 (en) Inhibition of protein-phosphatases for the treatment of heart failure
SI1534296T1 (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
AU2002251541A1 (en) Apparatus and assembly for administering antimicrobial agent
AU1522101A (en) Heparanase inhibitors for the treatment of heart failure
AU2003257591A1 (en) Preventive and/or therapeutic agent for heart failure
AU2003207275A1 (en) Preventive and/or therapeutic agent for cardiac disorder

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase